Monday - May 12, 2025
ALEXANDRIA, Va. / Jul 18, 2024 / Business Wire / Spok, Inc., a wholly owned subsidiary of Spok Holdings, Inc. (NASDAQ: SPOK) and a global leader in healthcare communications, is honored to announce that 17 of the 20 adult hospitals named to the 2024-2025 U.S. News & World Report Best Hospitals Honor Roll use Spok industry-leading secure healthcare communication solutions to facilitate care collaboration and support exceptional patient care. For over a decade, nearly every hospital named to the Best Hospitals Honor Rolls has relied on Spok solutions.
“We extend our heartfelt congratulations to our customers for their honor roll achievement. It’s our privilege to work alongside hospitals dedicated to excellence in patient care,” said Vincent D. Kelly, chief executive officer of Spok Holdings, Inc. “Our commitment to providing clinical communication solutions reflects our dedication to improving care team coordination and patient outcomes. We are grateful for the trust our customers place in Spok and remain steadfast in our mission to support their ongoing success."
The 2024-2025 recipients are among the more than 2,200 hospitals in the U.S. that rely on Spok solutions to effectively streamline healthcare communication and enhance patient care. U.S. News & World Report, the global authority in hospital rankings, has conducted the Best Hospitals rankings for more than 30 years. The adult honor roll recognizes 20 of the nation's highest performing hospitals across 15 specialties and 20 procedures and conditions. Approximately 4,500 hospitals are evaluated each year. The rankings are among the most referenced by consumers because they are based primarily on objective data, including risk-adjusted survival and readmission rates, discharge data, outcomes, volumes, patient experience, patient safety, and quality of nursing, among other care-related indicators.
About Spok
Spok, Inc., a wholly owned subsidiary of Spok Holdings, Inc. (NASDAQ: SPOK), headquartered in Alexandria, Virginia, is proud to be a global leader in healthcare communications. We deliver clinical information to care teams when and where it matters most to improve patient outcomes. Top hospitals rely on the Spok Care Connect® platform to enhance workflows for clinicians and support administrative compliance. Our customers send over 70 million messages each month through their Spok® solutions. Spok enables smarter, faster clinical communication. For more information, visit spok.com.
Spok is a trademark of Spok Holdings, Inc. Spok Care Connect is a trademark of Spok, Inc.
Last Trade: | US$16.25 |
Daily Change: | -0.21 -1.28 |
Daily Volume: | 170,864 |
Market Cap: | US$329.390M |
April 30, 2025 February 26, 2025 October 30, 2024 July 24, 2024 May 01, 2024 |
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MOREChimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MOREEnd of content
No more pages to load